This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Anticarcinogenic Agents; Erlotinib Hydrochloride; Mouth Neoplasms; Precancerous Conditions; Protein Kinase Inhibitors
|
|
information resource reference
|
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
|
|
label
|
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
|